about
A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesRecent advances in quantitative neuroproteomicsApolipoprotein A-I: insights from redox proteomics for its role in neurodegenerationAltered functional protein networks in the prefrontal cortex and amygdala of victims of suicideCerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiologySerum glycopattern and Maackia amurensis lectin-II binding glycoproteins in autism spectrum disorderPilot study of the application of magnetic bead protein profiling to the study of biomarkers in addiction research.Mass spectrometry as a tool for studying autism spectrum disorder.Protein and peptide profiling as a tool for biomarker discovery in depression.Multiplatform metabolome and proteome profiling identifies serum metabolite and protein signatures as prospective biomarkers for schizophrenia.Molecular neuropsychology: creation of test-specific blood biomarker algorithms.Proteomic analyses of limbic regions in neonatal male, female and androgen receptor knockout mice.Recent advances in applying mass spectrometry and systems biology to determine brain dynamics.Subclinical inflammatory status in Rett syndrome.Do we have any solid evidence of clinical utility about the pathophysiology of schizophrenia?Potential biomarkers in psychiatry: focus on the cholesterol system.Role of proteomics in biomarker discovery and psychiatric disorders: current status, potentials, limitations and future challenges.Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.Plasma biomarkers for Alzheimer's disease: much needed but tough to find.Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes.A network medicine approach to psychiatric genetics.The potential of biomarkers in psychiatry: focus on proteomics.Autism spectrum disorder: an omics perspective.Salivary proteomics and biomarkers in neurology and psychiatry.The emergence of point-of-care blood-based biomarker testing for psychiatric disorders: enabling personalized medicine.The potential biomarkers of drug addiction: Proteomic and metabolomic challenges.Expression and oxidative modifications of plasma proteins in autism spectrum disorders: Interplay between inflammatory response and lipid peroxidation.iTRAQ-Based Proteomics Suggests Ephb6 as a Potential Regulator of the ERK Pathway in the Prefrontal Cortex of Chronic Social Defeat Stress Model Mice.Proteomics in the Diagnosis of Inborn Encephalopathies of Unknown Origin: A Myth or Reality.Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.A pilot proteomic study of protein markers in autism spectrum disorder.Proteomics for blood biomarker exploration of severe mental illness: pitfalls of the past and potential for the future
P2860
Q26786354-AB6B3996-D339-4CE1-ABAE-508890F8F42CQ27000073-0155F150-5B84-40CD-A299-163D299DD6ADQ27026686-EB7A5ED1-A80F-4000-99BE-0ED7203466ADQ28485508-F41AF2F8-2E1E-4674-8897-60FD508B7448Q31043451-B8CCF4BA-88CE-481A-A671-9DB52EFA0D55Q33651921-4FAC3D63-14E8-4364-91B7-19CE105FB567Q34015109-B6D0A113-CC0F-4BA3-9BC2-519A70779AD0Q34470350-38AB73C3-F7B2-4F61-AA57-6F575D2B0940Q34480706-58A96089-E849-4CA4-9392-B409D8D49B5DQ35162008-310FDB31-0C44-4DD8-AA06-7B354F1DC7C5Q35456265-6522BFA3-D2B3-4552-B391-1E6179CA2120Q36240800-78F374C5-FC1C-4DA5-B225-9A38F466D4B0Q36379339-84515A41-E876-4519-87C2-F3DE2536BBA8Q37553416-32E89FF2-46E0-4296-BE81-26F4499C512CQ37850311-C8A04976-2DDE-4568-A664-2F5C8D2F97DBQ37981261-8495C55D-3405-445D-B121-59F19BB4F519Q38027217-FD9C17A8-70E7-4449-9601-4B9AC3D7720FQ38029716-FB71254F-BDAC-4626-ABD2-D01EB134ADCAQ38037157-A08112FC-2680-4FDE-920F-79A546ED896FQ38125769-00D6E19E-830D-4F00-870D-A81B2E0745C7Q38153339-8FCDBA2B-6491-439D-952C-2BE22744B4B1Q38172847-64F12138-D451-44E4-8C22-D7552B0D088AQ38259780-1B0EAE16-BA77-49B0-B842-95BC9AE6F28AQ38335930-D6CE570E-DD65-4D68-AB8F-3E81D7BDCBFFQ38783299-58C3DAF1-D5CB-4F49-BAC0-303ADFDDAB56Q38850141-709E7168-6DAC-4D37-A2D0-87EFC4A0A656Q39720986-C3EB3522-B146-4E7B-8FD7-0CE4C9D2E23EQ47670567-B7C8D7F0-7460-4039-AD6C-529267C9F90AQ47688592-CE978737-ACC3-4456-9CBB-2835A517ABA3Q48658510-66A02C32-5C0F-497F-8A9F-F6EF864C9B89Q50307879-25561DFF-E463-490E-AB82-42CF02030FCBQ57169146-A8499B24-C977-42F9-96FC-24FA63C5FCA6
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proteomic research in psychiatry.
@en
Proteomic research in psychiatry.
@nl
type
label
Proteomic research in psychiatry.
@en
Proteomic research in psychiatry.
@nl
prefLabel
Proteomic research in psychiatry.
@en
Proteomic research in psychiatry.
@nl
P2093
P2860
P356
P1476
Proteomic research in psychiatry.
@en
P2093
Andreas Warnke
Edward Dudley
Johannes Thome
Julia Grassl
Manfred Gerlach
Regina Taurines
P2860
P304
P356
10.1177/0269881109106931
P407
P577
2010-02-08T00:00:00Z